Professor and Chair of Pathology and Laboratory Medicine at the University of Rochester Medical Center, Dr. Smoller is a widely published and respected clinician, teacher, and international expert in dermatopathology.
Dr. Smoller's career has canvassed medical schools affiliated with Harvard, Stanford, Cornell, and the University of Arkansas. More recently, he served a term as executive vice president and secretary-treasurer for the 10,000-member United States and Canadian Academy of Pathology while simultaneously holding a faculty post at both Georgia Regents University (formerly Georgia Health Sciences University) and the Emory University School of Medicine.
Dr. Smoller belongs to a number of professional societies, including the American Society of Dermatopathology, where he took a turn as president and as a board member; the American Society of Clinical Pathologists; and the College of American Pathologists. Smoller spent five years as editor-in-chief of the Journal of Cutaneous Pathology and is frequently tapped for input on editorial boards for other preeminent journals in dermatology, pathology, and dermatopathology. Dr. Smoller has authored more than 200 peer-reviewed articles in leading journals plus 13 textbooks.
His primary research interests revolve around cutaneous T cell lymphoma and the role of immunopathology as a diagnostic tool.
Dr. Whitney-Miller is the Vice Chair for Anatomic Pathology at URMC, where she also serves as Director of Surgical Pathology and Associate Professor in the Department of Pathology & Laboratory Medicine.
She completed her residency in anatomic and clinical pathology at Hospital of the University of Pennsylvania, and earned her medical degree at SUNY Upstate Medical Center. She joined the University in 2009 and previously served as director of the gastrointestinal pathology service. As Director of Surgical Pathology, she has initiated several patient safety initiatives including bar code scanning in the histology laboratory. She looks forward to expanding these initiatives to the remainder of the laboratory, as well as working with the junior faculty on career development.
Her research focuses on HER2 overexpression in GI malignancies. She is also involved in interdepartmental collaborations with colleagues from the Wilmot Cancer Institute.
Dr. Burack is the Vice Chair for Clinical Operations in the Department of Pathology and Laboratory Medicine. He directs the Hematopathology division, which includes the Flow Cytometry Laboratory, tissue banking activities, and the Hematopathology Fellowship Program. This division works closely with Wilmot Cancer Institute and Pediatric Oncology to evaluate and diagnose lymphomas, leukemias, and related disorders. Burack also directs the Molecular Genetic Pathology unit, which includes laboratories conducting diagnostic genetic tests, such as DNA sequencing and chromosomal analyses. Molecular Genetic Pathology supports the care of patients throughout the medical center, from Wilmot to Obstetrics.
Dr. Burack's research interests include the molecular mechanisms of lymphoma progression and development of molecular methods to refine diagnostics, particularly of lymphomas and leukemias.
Dr. Findeis-Hosey is the Vice Chair of Educational Programs in the Department of Pathology and Laboratory Medicine, where she also directs the Gastrointestinal/Hepatobiliary Pathology group and serves as Director of Pathology Curriculum for the School of Medicine.
She received her MD from the Pennsylvania State University, after which she completed her residency in Anatomic and Clinical Pathology from the University of Rochester. Following a Surgical Pathology fellowship at the University of Michigan, she returned to Rochester to join the faculty at URMC.
Dr. Findeis-Hosey’s research interests include the engagement of students with and into Pathology, as well as multi-disciplinary care models for patients with Lynch Syndrome. As Vice Chair of Educational Programs, she is looking forward to supporting and further strengthening our already robust educational programs, from the pre-college Explorations In Pathology program to Residency and Fellowship programs.
Dr. Paczos is Associate Professor of Clinical Pathology and Laboratory Medicine at URMC, where she serves as the Director of the Regional Laboratory Division, Medical Director of the Central Laboratory at Bailey Road, and the Medical Director for the Maternal Serum Screening Program.
She completed her residency in combined anatomic and clinical pathology at the University of Buffalo School of Medicine and Biomedical Sciences. Dr. Paczos also completed a residency in Obstetrics and Gynecology at URMC and went on to earn her MS degree in Business administration at the UR’s Simon Business School.
Dr. Paczos is actively involved in laboratory administration. She is a member of the Chairs Cabinet, the Clinical Enterprise Group, and serves as Chair of the Regional Laboratory Task Force. She also recently joined the Board of the American Pathology Foundation, which is a national organization dedicated to pathology management. She is the co-course director of the Laboratory Management Rotation for the Pathology residency program, where she also directs an elective in Regional Pathology and is a resident mentor. Her areas of interest are laboratory administration, gynecologic pathology and general clinical pathology.
Dr. Zhang is the Vice Chair for Clinical Enterprise Strategy and Associate Professor of Pathology and Laboratory Medicine. She also serves as the Medical Director of Ambulatory Lab Services, Director of the Regional Toxicology and Mass Spectrometry Laboratory, and Associate Director of Clinical Chemistry at URMC.
She earned her PhD in Biochemistry and Bioinformatics from the University of Minnesota. Zhang later completed a clinical chemistry fellowship at Harvard Medical School and received her MBA from The Wharton School at University of Pennsylvania. She has served in numerous leadership positions for U.S. and international organizations including the American Association of Clinical Chemistry (AACC) for which she founded the Mass Spectrometry and Separation Sciences (MSSS) division.
Her research interests include clinical applications of mass spectrometry, toxicology, test utilization, transitioning of late phase discovery and -omics biomarkers to clinical services, and biomarkers for early diagnoses using -omics technologies.